DEF: Quantum Corp Seeks Stockholder Approval for $200 Million Equity Purchase Agreement
Proxy Statement
Quantum Corporation is seeking stockholder approval for the issuance of up to $200 million in common stock under a Standby Equity Purchase Agreement with YA II PN, Ltd. to comply with Nasdaq listing rules.
Summary
- Quantum Corporation is holding a special meeting of stockholders on April 24, 2025, to vote on three proposals.
- The first proposal is to approve the issuance of up to $200 million of common stock pursuant to a Standby Equity Purchase Agreement with YA II PN, Ltd. (Yorkville) dated January 25, 2025, and related change of control for purposes of complying with Nasdaq listing rule 5635.
- The agreement allows Quantum to sell shares to Yorkville over 36 months at its option, priced at either 96% of the VWAP or 97% of the lowest daily VWAP during a three-day period following an advance notice.
- The second proposal is to ratify the appointment of Grant Thornton LLP as the company's independent registered public accounting firm for the fiscal year ending March 31, 2026.
- The third proposal is to approve the adjournment of the Special Meeting to a later date, if necessary or appropriate.
- The Board of Directors recommends voting FOR all three proposals.
- Stockholders of record as of March 13, 2025, are entitled to vote at the Special Meeting.
- The company has engaged Alliance Advisors LLC to assist in the solicitation of proxies for a fee of $25,000 plus expenses.
Sentiment
Score: 6
Explanation: The document is neutral to slightly positive. It outlines a plan for potential capital raising, which could be beneficial, but also highlights potential dilution and business challenges.
Positives
- The Standby Equity Purchase Agreement with Yorkville provides Quantum with a potential source of capital to be used for working capital, general corporate purposes, and repayment of debt.
- Ratification of Grant Thornton LLP as the independent auditor supports good corporate governance.
- The Adjournment Proposal provides flexibility to solicit additional proxies if needed.
Negatives
- The sale of common stock to Yorkville will have a dilutive impact on existing stockholders.
- Failure to obtain stockholder approval for the Nasdaq Proposal will limit the company's ability to utilize the full amount available under the Purchase Agreement, potentially impacting liquidity.
- The company has experienced business challenges and incurred restructuring expenses, which may necessitate additional liquidity.
Risks
- The company's business may soften, and it may not meet its business objectives, plans, or forecasts, requiring additional liquidity.
- Failure to obtain stockholder approval for the Nasdaq Proposal could have a material adverse effect on the company's business.
- The sale of common stock to Yorkville will dilute the economic and voting interests of existing stockholders.
- There is no guarantee that the company will be able to access the full $200 million under the Purchase Agreement.
Future Outlook
The company expects that any proceeds received from sales to Yorkville will be used for working capital and general corporate purposes, including the repayment of debt.
Management Comments
- The Board of Directors recommends that you vote FOR the Nasdaq Proposal, FOR the Ratification Proposal, and FOR the Adjournment Proposal, as such proposals are more fully described in the accompanying Proxy Statement.
- Your vote is very important regardless of the number of shares that you own and we encourage you to vote promptly.
Industry Context
Standby equity purchase agreements are a financing tool used by companies to access capital, but they can also lead to stock dilution. Stockholder approval is often required by exchanges like Nasdaq when the issuance exceeds a certain threshold or could result in a change of control.
Comparison to Industry Standards
- The terms of the Standby Equity Purchase Agreement, such as the discount to VWAP (96% or 97%), are within the typical range for these types of agreements.
- The requirement for stockholder approval for issuances exceeding 19.99% of outstanding shares is standard practice to comply with Nasdaq listing rules, similar to requirements faced by other publicly traded companies.
- The engagement of a proxy solicitor like Alliance Advisors LLC is a common practice for companies seeking to ensure sufficient stockholder participation in important votes, mirroring strategies employed by other firms in similar situations.
Stakeholder Impact
- Approval of the Nasdaq Proposal will allow the company to access additional capital, potentially benefiting the company and its stakeholders.
- Failure to approve the Nasdaq Proposal could limit the company's access to capital, potentially impacting its ability to execute its business plan.
- The sale of common stock to Yorkville will dilute the economic and voting interests of existing stockholders.
Next Steps
- Stockholders need to vote on the proposals outlined in the proxy statement.
- The company will hold a Special Meeting of Stockholders on April 24, 2025, to vote on the proposals.
- The company will continue to seek stockholder approval at subsequent special meetings if the Nasdaq Proposal is not approved at the initial meeting.
Key Dates
| Date | Description |
|---|---|
| January 25, 2025 | Date of the Standby Equity Purchase Agreement with YA II PN, Ltd. (Yorkville). |
| March 4, 2025 | Deadline for stockholders to submit proposals for inclusion in the company's proxy materials for the 2025 annual meeting. |
| March 13, 2025 | Record Date for determining stockholders entitled to notice of and to vote at the Special Meeting. |
| March 27, 2025 | Expected date of mailing proxy materials to stockholders of record. |
| April 18, 2025 | Earliest date for stockholders to submit proposals or director nominations for the 2025 annual meeting without inclusion in the proxy materials. |
| April 23, 2025 | Deadline to register for the virtual Special Meeting by 11:59 p.m., Eastern Time. |
| April 23, 2025 | Proxies transmitted by Internet or Telephone must be submitted prior to 11:59 p.m., Eastern Time. |
| April 24, 2025 | Date of the Special Meeting of Stockholders at 8:30 a.m., Pacific Time. |
| May 18, 2025 | Latest date for stockholders to submit proposals or director nominations for the 2025 annual meeting without inclusion in the proxy materials. |
| June 16, 2025 | Deadline for stockholders intending to solicit proxies in support of director nominees other than Quantum's nominees to provide notice with information required by Rule 14a-19 under the Exchange Act. |
| March 31, 2026 | Fiscal year ending date for which Grant Thornton LLP is being considered for ratification as the independent registered public accounting firm. |
Keywords
proxy statement, stockholder meeting, common stock, equity purchase agreement, Nasdaq, Grant Thornton, Yorkville, dilution, liquidity, voting
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.